Andone Pharmaceuticals

What Andone Pharmaceuticals does

Andone Pharmaceuticals (operating as Andone Pharma) is a privately held Canadian pharmaceutical and medical device company headquartered in Oakville, Ontario. Founded in 2018, the company focuses on \u201cbringing new life to mature molecules\u201d, commercializing established generic pharmaceutical products rather than developing novel therapeutics. Its portfolio spans injectable oncology agents (cyclophosphamide, doxorubicin, Tepadina/thiotepa, Leukeran/chlorambucil), anesthetic and sedative injectables (Diprivan/propofol, Sensorcaine/bupivacaine, Xylocaine/lidocaine, Emla cream), oral neurology and pain products (gabapentin, levetiracetam, fluoxetine), and anti-infectives (metronidazole), distributed as 13+ branded and generic SKUs across multiple therapeutic classes.

The company pairs its pharmaceutical arm with a medical device portfolio addressing medication preparation and delivery. Core devices include Closed System Transfer Device (CSTD) kits that integrate third-party safety devices from BD Phaseal Optima and Equashield for handling hazardous drugs, sterile compounding syringes packaged in convenience trays for pharmacy compounding, Medi-Flo elastomeric disposable infusion pumps for bolus, antibiotic, and chemotherapy infusions, a Vial-Bag Plus reconstitution adapter that connects a drug vial directly to an IV bag, tamper-evident syringe caps, and specialty syringe-and-needle products. A strategic compounding partnership with R\u00eave Pharma extends the company's reach into Drug Preparation Premises services.

Commercially, Andone operates a direct B2B sales model targeting Canadian healthcare institutions\u2014hospitals, clinics, and pharmacies\u2014with contact-based pricing rather than publicly disclosed price lists. Distribution is exclusively domestic (Canada) and relies on enterprise field sales supported by the company's website as the primary digital presence. The company maintains 11\u201350 employees, holds Health Canada regulatory licensure for its marketed drug products, and is positioned as a mid-sized specialty supplier with stated goals of simplifying healthcare delivery workflows for clinicians and pharmacy staff.

Name

Andone Pharmaceuticals

Legal name

Andone Pharma

Website

https://andonepharma.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Andone Pharmaceuticals is a Canadian specialty pharmaceutical and medical device company that markets established generic injectable and oral drugs alongside medication preparation and delivery devices to hospitals, clinics, and pharmacies across Canada.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals and Medical Devices

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Surgical Appliance and Supplies Manufacturing (339113), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)

akta.pro secondary industries

Generic Hospital & Institutional Products (HLAIABAL), Specialty Care Pharmaceuticals (HLAIAAAB), Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)

Keywords

• Generic pharmaceuticals
• Medical devices
• Injectable medications
• Sterile compounding
• Closed system transfer

Headquarters

HQ city

Oakville

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Sale of established/generic pharmaceutical products including injectables, tablets, and creams. Products include cyclophosphamide, propofol, doxorubicin, lidocaine-based products, and other medications.
2. Medical Device Sales: Sale of medical devices including syringes, needles, infusion pumps, closed system transfer devices, compounding supplies, and vial-to-bag adapters.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Andone Pharma sells a portfolio of established-molecule (generic) pharmaceutical products—including injectable oncology agents, anesthetics, sedatives, analgesics, antibiotics, and topical anesthetics—alongside medical devices used for medication preparation and delivery such as infusion pumps, sterile compounding syringes, closed system transfer device kits, syringe tamper-evident caps, and a vial-to-bag reconstitution adapter. Products are sold directly to Canadian healthcare institutions including hospitals, clinics, and hospital/clinical pharmacies.

Product overview

Andone Pharma is a Canadian pharmaceutical and medical device company offering a broad portfolio of mature-molecule drug products and medication delivery devices. Its pharmaceutical arm includes injectable oncology agents (cyclophosphamide, doxorubicin, thiotepa), anesthetic/sedative agents (propofol, bupivacaine, lidocaine), analgesics (gabapentin, lidocaine jelly), antibiotics (metronidazole), neurological medications (levetiracetam, fluoxetine), and a topical anesthetic (Emla cream). Its medical device portfolio centers on medication preparation and delivery solutions including syringe and needle products, Closed System Transfer Device (CSTD) kits integrating BD Phaseal™ Optima and Equashield®, sterile compounding syringes, Medi-Flo® elastomeric infusion pumps, syringe tamper-evident caps, and the Vial-Bag Plus reconstitution adapter. The company also holds a strategic partnership with Rêve Pharma for compounding services. Together, these products serve hospital, clinic, and pharmacy settings across Canada, with a stated mission to simplify daily healthcare tasks and reduce system complexity.

Differentiator

Problem solved

Functional benefit

Products and services

• Cyclophosphamide Injection Injectable alkylating agent used in oncology, available in 1 g and 2 g vial presentations for reconstitution. Sold to hospitals, clinics, and pharmacies.
• Diprivan (propofol) 1% Injectable sedative-hypnotic agent used for anesthesia induction and maintenance, supplied in 20 mL, 50 mL, and 100 mL vials for hospitals and surgical settings.
• Doxorubicin 2 mg/mL Anthracycline chemotherapy agent supplied as a 25 mL vial for oncology applications in hospitals and infusion centers.
• Emla Cream (lidocaine & prilocaine) Topical anesthetic cream (lidocaine 2.5% and prilocaine 2.5%) supplied in a 30 g tube for surface anesthesia.
• Fluoxetine Selective serotonin reuptake inhibitor (SSRI) antidepressant available in 10 mg and 20 mg oral tablet formulations.
• Gabapentin Anticonvulsant/neuropathic pain agent available in 100 mg, 300 mg, 400 mg, 600 mg, and 800 mg oral capsule/tablet formulations.
• Leukeran (chlorambucil) Alkylating agent used in oncology, supplied as 2 mg oral tablets.
• Levetiracetam Anticonvulsant medication for seizure management, available in 250 mg, 500 mg, and 750 mg oral tablet formulations.
• Metronidazole 500 mg Antimicrobial/anti-infective agent available in oral tablet form for bacterial and parasitic infections.
• Sensorcaine (bupivacaine) Long-acting local anesthetic available in 0.5% and 0.25% injectable concentrations for regional anesthesia in surgical settings.
• Tepadina (thiotepa) Alkylating chemotherapy agent available in 15 mg and 100 mg single vials and a 400 mg multichamber bag for oncology use.
• Xylocaine (lidocaine) 2% Local anesthetic supplied in 20 mL and 50 mL multi-dose vials for injection.
• Xylocaine (lidocaine) 2% Jelly Topical/local anesthetic preparation supplied in a 30 mL tube for surface anesthesia.
• Syringe and Needle Syringes and needles designed for medication delivery applications, including a 0.3 mL syringe with 31G x 5/16" needle for precision dosing in clinical settings.
• Closed System Transfer Device (CSTD) Kit Kits combining hazardous drugs with closed system transfer devices from BD Phaseal Optima and Equashield to protect healthcare workers from exposure during preparation and administration of hazardous medications. Includes an electronic Instructions for Use (eIFU).
• Sterile Compounding Syringe Sterile compounding syringes intended for the compounding process in pharmacies and clinics, used to mix, reconstitute, dilute, and administer medications. Packaged in convenience trays with a full line of luer lock syringe sizes.
• Medi-Flo Elastomeric Disposable Infusion Pump Elastomeric disposable infusion pumps for delivering medications including single bolus doses, antibiotic infusions, and chemotherapy infusions across multiple healthcare settings. Available in multiple container sizes and flow rates.
• Syringe Tamper Evident Caps Tamper-evident caps for syringes designed to ensure secure handling of sensitive medications during storage and transport.
• Vial-Bag Plus Reconstitution and Fluid Transfer Device A simple adapter device that directly connects a drug vial to an IV bag for efficient reconstitution and fluid transfer during preparation.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Partnerships

One partnership is on record.

• Rêve PharmacoreStrategic or Co-development PartnerRêve Pharma is a licensed Drug Preparation Premises and compounding provider. The partnership combines pharmaceutical products with delivery devices in unique presentations that directly meet the needs of clinicians and caregivers. The collaboration allows for innovative product configurations leveraging Reve Pharma's compounding expertise with Andone's pharmaceutical and device portfolio. Website: www.revepharma.ca

Recent moves5 records

Expansion highlights4 records

Market position

Competitive moat2 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/andonepharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Andone Pharmaceuticals